1. Study identification
EU PAS Register NumberEUPAS28126
Official titleNon-traumatic Haemorrhagic Adverse Events: A Cross-sectional Study in Emergency Departments
Study title acronymHARER
Study typeObservational study
Brief description of the studyBleeding is a common clinical emergency that requires urgent medical attention. There is a general clinical interest in haemorrhages, which is increasing due to the recent introduction of new oral anti-coagulant drugs. Data about the incidence of bleeding in Emergency Room (ER) are lacking in literature, even if several studies report emergency admissions for haemorrhages associated with specific drugs or apparatuses. The retrospective observational study Haemorrhagic Adverse Reactions in Emergency Room (HARER) was designed in order to estimate the incidence of bleeding events and the incidence of suspected haemorrhagic adverse drug reactions as causes of Emergency Room visits. HARER takes into consideration the computerized medical records from two Emergency Departments of the University Hospital in Verona (Italy) from 2015 to 2016 over a twelve month period. According to a validated list available in literature , patients aged ≥ 18 years with an International Classification of Diseases, 9th Revision (ICD-9) diagnosis code at admission related to haemorrhage, but not caused by traumatic events, were included in the study. Unique identification code of the patient with a bleeding episode (as anonymization procedure), date of birth, gender, ICD-9 code, diagnosis at admission, complete patient’s medical history and outcome were recorded. Data were extrapolated from the First Aid database, which contains evaluation at admission, medical history, concomitant pharmacological treatment, descriptive discharge diagnosis, its corresponding ICD-9 CM code and outcome.Haemorrhages were classified into 5 groups: cerebral haemorrhage, gastrointestinal bleeding, epistaxis, haematuria and other haemorrhages.Drugs known to beassociated with haemorrhagic events were grouped into six categories:anticoagulants, antiplatelet drugs, heparins, SSRIs and NSAIDs, and we considered suspected haemorrhagic ADEs in all patient records reporting at least one of these drugs.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)?
Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Department/Research groupPharmacology Unit - Veneto Pharmacovigilance Centre
Organisation/affiliationUniversity Hospital Verona
Details of (Primary) lead investigator
Title Professor
Last name Roberto
First name Leone
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)
Countries in which this study is being conducted
National study
Italy
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed09/12/201509/12/2015
Start date of data collection01/02/201601/02/2016
Start date of data analysis01/08/2016
Date of interim report, if expected
Date of final study report01/08/201706/04/2018
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesBayer100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Professor
Last name Roberto
First name Leone
Address line 1Pharmacology Unit
Address line 2Policlinico GB Rossi
Address line 3P.le L.A. Scuro 10
CityVerona
Postcode37134
CountryItaly
Phone number (incl. country code)390458124706
Alternative phone number390458027612
Fax number (incl. country code)390458124876
Public Enquiries
Title Professor
Last name Roberto
First name Leone
Address line 1Pharmacology Unit
Address line 2Policlinico GB Rossi
Address line 3P.le L.A. Scuro 10
CityVerona
Postcode37134
CountryItaly
Phone number (incl. country code)390458124706
Alternative phone number390458027612
Fax number (incl. country code)390458124876
6. Study drug(s) information
Not applicable (disease/epidemiology study)
7. Medical conditions to be studied
Medical condition(s)Yes
Haemorrhagic disorder
8. Population under study
Age
Adults (18 - 44 years)
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Sex
Male
Female
9. Number of subjects
Estimated total number of subjects118000
Additional information
adult patients(≥18years).Cases were identified in 2 EDs of the Hospital ofVerona (population of about 300,000 inhabitants).All patients accessing from 1 February 2015 to 31 July 2015 and from 1 February 2016 to 31 July 2016,having an International Classification of Diseases, Clinical Modification code of discharge related to haemorrhage without concomitant diagnosis of trauma,were included
10. Source of data
Is this study being carried out with an established data source?No
Sources of data
Cross-sectional study. Data were extrapolated from the First Aid database
11. Scope of the study
What is the scope of the study?
Risk assessment
Primary scope : Risk assessment
12. Main objective(s)
What is the main objective of the study?
Our aims were to describe the incidence of haemorrhages and adverse
drug events (ADEs) related to different classes of drugs as cause of ED admission, the characteristics of patients, the kind of bleeding and the
description of hospitalizations and intra-hospital deaths.
Are there primary outcomes?Yes
To estimate the incidence of hemorrhagic patients entering the
emergency department during the study period
Are there secondary outcomes?No
13. Study design
What is the design of the study?
Cross-sectional study
14. Follow-up of patients
Will patients be followed up?Not applicable/no follow-up
15. Data analysis plan
Please provide a brief summary of the analysis method
To estimate the incidence of hemorrhagic patients entering the
emergency department during the study period we calculated the ratio
between the patients with an ICD-9 DM diagnosis that code for a
haemorrhage respect to all patients who entered in the same period.
Descriptive baseline characteristics were expressed in percentages and
means ± standard deviation of the mean. Data about hemorrhage and
drugs are presented as percentage since they are categorical variables.